113 related articles for article (PubMed ID: 31678529)
1. In vivo evaluation of targeted delivery of biological agents using barium sulfate.
Labelle MA; Ispas-Szabo P; Masseau I; Chorfi Y; Mateescu MA
Int J Pharm; 2019 Dec; 572():118801. PubMed ID: 31678529
[TBL] [Abstract][Full Text] [Related]
2. Carboxymethyl Starch Excipients for Drug Chronodelivery.
Ispas-Szabo P; De Koninck P; Calinescu C; Mateescu MA
AAPS PharmSciTech; 2017 Jul; 18(5):1673-1682. PubMed ID: 27686941
[TBL] [Abstract][Full Text] [Related]
3. Carboxymethyl-starch excipients for gastrointestinal stable oral protein formulations containing protease inhibitors.
De Koninck P; Archambault D; Hamel F; Sarhan F; Mateescu MA
J Pharm Pharm Sci; 2010; 13(1):78-92. PubMed ID: 20456833
[TBL] [Abstract][Full Text] [Related]
4. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
[TBL] [Abstract][Full Text] [Related]
5. Design of Catalase Monolithic Tablets for Intestinal Targeted Delivery.
Alothman M; Ispas-Szabo P; Mateescu MA
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33430270
[TBL] [Abstract][Full Text] [Related]
6. A novel oral colon-targeting drug delivery system based on resistant starch acetate.
Chen L; Pu H; Li X; Yu L
J Control Release; 2011 Nov; 152 Suppl 1():e51-2. PubMed ID: 22195921
[No Abstract] [Full Text] [Related]
7. Carboxymethyl starch: Chitosan monolithic matrices containing diamine oxidase and catalase for intestinal delivery.
Calinescu C; Mondovi B; Federico R; Ispas-Szabo P; Mateescu MA
Int J Pharm; 2012 May; 428(1-2):48-56. PubMed ID: 22402476
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of disintegrants functionality for orodispersible mini tablets.
Soulairol I; Chaheen M; Tarlier N; Aubert A; Bataille B; Sharkawi T
Drug Dev Ind Pharm; 2017 Nov; 43(11):1770-1779. PubMed ID: 28581832
[TBL] [Abstract][Full Text] [Related]
9. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
Meka VS; Yee P; Sheshala R
Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
[TBL] [Abstract][Full Text] [Related]
10. Ionotropically cross-linked pH-sensitive IPN hydrogel matrices as potential carriers for intestine-specific oral delivery of protein drugs.
El-Sherbiny IM; Salama A; Sarhan AA
Drug Dev Ind Pharm; 2011 Feb; 37(2):121-30. PubMed ID: 20615156
[TBL] [Abstract][Full Text] [Related]
11. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
Le TC; Mateescu MA
Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
[TBL] [Abstract][Full Text] [Related]
12. Simplified formulations with high drug loads for continuous twin-screw granulation.
Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
[TBL] [Abstract][Full Text] [Related]
13. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
Assaad E; Mateescu MA
Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
[TBL] [Abstract][Full Text] [Related]
14. Fast- and slow-release tablets for oral administration of flavonoids: rutin and quercetin.
Lauro MR; Torre ML; Maggi L; De Simone F; Conte U; Aquino RP
Drug Dev Ind Pharm; 2002 Apr; 28(4):371-9. PubMed ID: 12056530
[TBL] [Abstract][Full Text] [Related]
15. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
Czarnocka JK; Alhnan MA
Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126
[TBL] [Abstract][Full Text] [Related]
16. Self-stabilized chitosan and its complexes with carboxymethyl starch as excipients in drug delivery.
Leonida M; Ispas-Szabo P; Mateescu MA
Bioact Mater; 2018 Sep; 3(3):334-340. PubMed ID: 29988516
[TBL] [Abstract][Full Text] [Related]
17. Influence of barium sulfate X-ray imaging contrast material on properties of floating drug delivery tablets.
Diós P; Szigeti K; Budán F; Pócsik M; Veres DS; Máthé D; Pál S; Dévay A; Nagy S
Eur J Pharm Sci; 2016 Dec; 95():46-53. PubMed ID: 27687639
[TBL] [Abstract][Full Text] [Related]
18. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
Yang B; Wei C; Yang Y; Wang Q; Li S
Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
[TBL] [Abstract][Full Text] [Related]
19. Development and in vitro evaluation of an abuse-deterrent formulation based on a crosslinked starch derivative.
Ahmad R; Omidian H
Int J Pharm; 2019 Oct; 569():118602. PubMed ID: 31394182
[TBL] [Abstract][Full Text] [Related]
20. Polyelectrolyte complex of carboxymethyl starch and chitosan as protein carrier: oral administration of ovalbumin.
Assaad E; Blemur L; Lessard M; Mateescu MA
J Biomater Sci Polym Ed; 2012; 23(13):1713-28. PubMed ID: 21967707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
